MedCity News

APRIL 27, 2025

Many of those who survive the loss, devastation, and displacement of an extreme climate event such as a flood, tornado, drought, or wildfire experience anxiety, depression, post-traumatic stress disorder (PTSD), and even suicidal thoughts. Similar mental illnesses are often found even when people are indirectly exposed to extreme climate events. The post The Silent Mental Health Crisis of Climate Change appeared first on MedCity News.

Education 298

Education Medical Patients Healthcare 298

PharmaVoice

MAY 2, 2025

Regulators have signaled their willingness to embrace alternative tests and guide the industry in new directions.

Pharma 194

Pharma 194

pharmaphorum

MAY 2, 2025

Shares in Eli Lilly have weakened after pharmacy benefit manager CVS Health said it would no longer cover its weight-loss therapy Zepbound.

Management 100

Management 100

Pharmatutor

MAY 2, 2025

List of Drug patent expiration 2025 admin Fri, 05/02/2025 - 14:05 Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices.

Competition 94

Competition Manufacturing Medical Marketing 94

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

MAY 2, 2025

AI addresses the disconnect between recommended guidelines and action by increasing engagement with personalized, actionable education and updates at appropriate times, The post AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine appeared first on MedCity News.

Medicine 308

Medicine Patients Education Physicians 308

pharmaphorum

MAY 2, 2025

A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US.

66

66

Pharma Marketing Network

APRIL 28, 2025

Introduction Imagine standing at the edge of a revolution, where every tool you need to succeed is finally within reach. That’s precisely where pharmaceutical marketers find themselves today. Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations.

Marketing 59

Marketing Pharma Education Networking 59

MedCity News

APRIL 27, 2025

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding pharmacies must stop making their versions of the metabolic medicines or face FDA enforcement action. The post Novo Nordisk Notches a Court Win Against Wegovy and Ozempic Compounders appeared first on MedCity News.

FDA 253

FDA Medicine Biopharma Pharma 253

PharmaVoice

APRIL 28, 2025

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

FDA 170

FDA Pharma 170

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

pharmaphorum

MAY 2, 2025

A planning application has been filed to invest 1bn in "the world's leading centre for cancer research and treatment" in London.

Leads 64

Leads 64

Pharma Marketing Network

APRIL 29, 2025

Introduction Is traditional advertising losing its edge in the pharmaceutical world? As the industry shifts toward data-driven strategies, the power of audience targeting continues to redefine how brands connect with healthcare professionals (HCPs) and patients. While print ads, radio spots, and mass media campaigns once dominated, the ability to reach the right person at the right time through digital channels has quickly taken the lead.

Pharma 59

Pharma Marketing Media Healthcare 59

MedCity News

APRIL 27, 2025

EMS providers often treat patients without medical history, risking delays, errors, and guesswork. But new national data-sharing frameworks are starting to close that gap, bringing critical records to first responders in real time. The post Bringing Patient Data to the Frontlines: Why Interoperability Must Include EMS appeared first on MedCity News.

Patients 240

Patients Medical 240

Spotio

MAY 1, 2025

Imagine walking into your next sales meeting and the prospect already knows your name, your expertise, and sees you as a trusted expert. Thats the power of social selling for outside sales pros. Today, building relationships starts long before the first handshake often with a thoughtful comment, a shared article, or a personalized message on LinkedIn.

Sales 52

Sales Prospecting CRM Sales pipeline 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaVoice

APRIL 30, 2025

A leaked document revealed details about changes that could impact how the agency operates, but recent comments from FDA Commissioner Dr. Marty Makary have muddied the picture.

FDA 147

FDA 147

Pharma Marketing Network

MAY 1, 2025

Introduction In the rapidly evolving pharmaceutical landscape, staying abreast of emerging pharma trends is crucial for maintaining a competitive edge. As we navigate through 2025, several key developments are reshaping the industry, from technological advancements to regulatory reforms. Understanding these trends not only aids in strategic planning but also ensures alignment with industry standards and patient expectations.

Pharma 52

Pharma Marketing Training Education 52

MedCity News

APRIL 29, 2025

For employers to offer effective, accessible and affordable value-based care for their employees, they must address these four components. The post How Employers Can Leverage Value-Based Care to Drive Retention and Improved Health Outcomes for Employees appeared first on MedCity News.

273

273

PharmaTech

MAY 2, 2025

While global harmonization exists, there are still differences between the US and European GMP requirements that manufacturers should know, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

Manufacturing 59

Manufacturing 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MAY 2, 2025

More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi has been given the go-ahead by the agency

FDA 59

FDA Pharma 59

Pharma Marketing Network

APRIL 27, 2025

Introduction In todays hyper-competitive healthcare space, building a Lead Generation Network in pharma is no longer optionalits essential. Much like a clinical trial needs carefully selected participants, pharma marketers must construct targeted networks to generate high-quality leads. But how does one translate an abstract marketing concept into a practical strategy that complies with strict regulatory frameworks while producing measurable outcomes?

Networking 52

Networking Leads Pharma Education 52

MedCity News

APRIL 29, 2025

Abeona Therapeutics makes Zevaskyn by engineering a patients biopsied skin cells to express the collagen that they lack, then growing those cells into sheets that can be surgically applied to a wound. Abeona’s cell-based gene therapy is just the third FDA-approved treatment for epidermolysis bullosa, a rare disease that leads to skin described as thin and fragile like a butterflys wings.

FDA 205

FDA Engineering Leads Patients 205

PM360

MAY 2, 2025

In oncology, breakthroughs in treatment are revolutionizing care for cancer patients worldwide. Antibody-Drug Conjugates (ADCs) represent a significant advancement, offering targeted therapies that precisely deliver potent drugs to cancer cells, minimizing damage to healthy tissue. To delve into the potential and ongoing innovation in ADCs, as well as explore strategic partnerships shaping the future of cancer care, industry leaders Partha Anbil, Mike Wong and Ken Keller , President & CEO of

Medicine 52

Medicine Competition Government Patients 52

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

European Pharmaceutical Review

APRIL 28, 2025

Over the next few years, there are virtually no aspects of pharmaceutical manufacturing processes that will not be changed by artificial intelligence (AI). By harnessing AIs capabilities to analyse complex datasets, identify subtle patterns and make precise predictions, biopharmaceutical manufacturers will be able to achieve unprecedented levels of process optimisation, quality assurance and operational efficiency.

Pharmaceutical 59

Pharmaceutical Manufacturing Pharmaceutical manufacturing Ethics 59

Pharma Marketing Network

APRIL 29, 2025

Introduction When was the last time a glossy pharma ad truly resonated with a patient living with chronic illness? In today’s healthcare marketing landscape, trust is the new currencyand real stories matter more than polished commercials. Thats why Influencer Marketing In Pharma is gaining momentum as a critical tool for reaching audiences in a more authentic, impactful way.

Marketing 52

Marketing Pharma Education Patients 52

MedCity News

APRIL 28, 2025

SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. The post Merck KGaAs Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition appeared first on MedCity News.

FDA 245

FDA Biopharma Pharma 245

PharmaVoice

MAY 1, 2025

Turmoil at the NIH has led to handwringing among researchers and drugmakers who rely on public funding.

130

130

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

European Pharmaceutical Review

MAY 2, 2025

The US Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) as the first autologous cell-based gene therapy for treating recessive dystrophic epidermolysis bullosa (RDEB) wounds. Also known as pz-cel, the cell sheet-based treatment is applied via a single surgical application. The gene therapy uses a patients keratinocyte cells that have been genetically modified, so that they produce functional Type VII collagen, Abeona Therapeutics explained.

Food and Drug Administration 52

Food and Drug Administration FDA Food Patients 52

Pharma Marketing Network

MAY 2, 2025

Trust is no longer a luxury in healthcare marketingits a necessity. In an era where misinformation spreads faster than facts, crafting a healthcare brand strategy that inspires confidence is more essential than ever. As consumers, providers, and payers grow increasingly skeptical of institutional messaging, brands must work harder to earn loyalty. But how do you build trust in a digital ecosystem thats constantly shifting?

Healthcare 52

Healthcare Healthcare Pharma Education 52

MedCity News

APRIL 28, 2025

The status quo for medical malpractice insurance is no longer good enough. While we must always prioritize the need for accountability when it comes to medical malpractice, we must also consider how challenges like increased premiums, rising costs and new risks are impacting providers and consequentially patients. The post Its Time for Medical Malpractice Insurance to Emerge from the Stone Age appeared first on MedCity News.

Insurance 243

Insurance Medical Patients Physicians 243